搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bifidobacterium longum Peptide deformylase 1 (def1) CSB-YP811427BGP
CSB-EP811427BGP
CSB-BP811427BGP
CSB-MP811427BGP
CSB-EP811427BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Pyridoxal biosynthesis lyase pdxS (pdxS) CSB-YP811428BGP
CSB-EP811428BGP
CSB-BP811428BGP
CSB-MP811428BGP
CSB-EP811428BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Elongation factor G (fusA), partial CSB-YP811429BGP
CSB-EP811429BGP
CSB-BP811429BGP
CSB-MP811429BGP
CSB-EP811429BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Thiazole synthase (thiG) CSB-YP811430BGP
CSB-EP811430BGP
CSB-BP811430BGP
CSB-MP811430BGP
CSB-EP811430BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Bifunctional protein FolD (folD) CSB-YP811431BGP
CSB-EP811431BGP
CSB-BP811431BGP
CSB-MP811431BGP
CSB-EP811431BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Alanine--tRNA ligase (alaS), partial CSB-YP811432BGP
CSB-EP811432BGP
CSB-BP811432BGP
CSB-MP811432BGP
CSB-EP811432BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Glutamate-ammonia-ligase adenylyltransferase (glnE), partial CSB-YP811433BGP
CSB-EP811433BGP
CSB-BP811433BGP
CSB-MP811433BGP
CSB-EP811433BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum ATP phosphoribosyltransferase (hisG) CSB-YP811434BGP
CSB-EP811434BGP
CSB-BP811434BGP
CSB-MP811434BGP
CSB-EP811434BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP811435BGP
CSB-EP811435BGP
CSB-BP811435BGP
CSB-MP811435BGP
CSB-EP811435BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Heat-inducible transcription repressor HrcA (hrcA) CSB-YP811436BGP
CSB-EP811436BGP
CSB-BP811436BGP
CSB-MP811436BGP
CSB-EP811436BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum UvrABC system protein C (uvrC), partial CSB-YP811437BGP
CSB-EP811437BGP
CSB-BP811437BGP
CSB-MP811437BGP
CSB-EP811437BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Probable serine/threonine-protein kinase pknB (pknB), partial CSB-YP811438BGP
CSB-EP811438BGP
CSB-BP811438BGP
CSB-MP811438BGP
CSB-EP811438BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Ketol-acid reductoisomerase 1 (ilvC1) CSB-YP811439BGP
CSB-EP811439BGP
CSB-BP811439BGP
CSB-MP811439BGP
CSB-EP811439BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Formate--tetrahydrofolate ligase (fhs), partial CSB-YP811440BGP
CSB-EP811440BGP
CSB-BP811440BGP
CSB-MP811440BGP
CSB-EP811440BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase (glgE), partial CSB-YP811441BGP
CSB-EP811441BGP
CSB-BP811441BGP
CSB-MP811441BGP
CSB-EP811441BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP811442BGP
CSB-EP811442BGP
CSB-BP811442BGP
CSB-MP811442BGP
CSB-EP811442BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Phosphate import ATP-binding protein PstB (pstB) CSB-YP811443BGP
CSB-EP811443BGP
CSB-BP811443BGP
CSB-MP811443BGP
CSB-EP811443BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Phosphopantetheine adenylyltransferase (coaD) CSB-YP811444BGP
CSB-EP811444BGP
CSB-BP811444BGP
CSB-MP811444BGP
CSB-EP811444BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Lipoprotein signal peptidase (lspA), partial CSB-YP811445BGP1
CSB-EP811445BGP1
CSB-BP811445BGP1
CSB-MP811445BGP1
CSB-EP811445BGP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Elongation factor P (efp) CSB-YP811446BGP
CSB-EP811446BGP
CSB-BP811446BGP
CSB-MP811446BGP
CSB-EP811446BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>